Leerink Partners analyst Richard Newitter maintained a Hold rating on Intuitive Surgical (NASDAQ:ISRG) on Friday, setting a price target of $725, which is approximately 2.16% below the present share price of $741.
Newitter expects Intuitive Surgical to post earnings per share (EPS) of $0.58 for the fourth quarter of 2020.
The current consensus among 18 TipRanks analysts is for a Moderate Buy rating of shares in Intuitive Surgical, with an average price target of $733.35.
The analysts price targets range from a high of $815 to a low of $365.
In its latest earnings report, released on 06/30/2020, the company reported a quarterly revenue of $852.1 million and a net profit of $80.6 million. The company's market cap is $86.72 billion.
According to TipRanks.com, Leerink Partners analyst Richard Newitter is currently ranked with 5 stars on a 0-5 stars ranking scale, with an average return of 23.4% and a 70.10% success rate.
Intuitive Surgical, Inc. engages in the development, manufacture, and marketing of da Vinci Surgical Systems, and related instruments and accessories for invasive surgery. Its products include Da Vinci and Ion. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.